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Abstract: Matching tissue engineering scaffold modulus
to that of native tissue is highly desirable. Effective scaffold
modulus can be altered through changes in base material
modulus and/or scaffold pore architecture. Because the lat-
ter may be restricted by tissue in-growth requirements, it is
advantageous to be able to alter the base material modulus
of a chosen scaffold material. Here, we show that the bulk
modulus of poly(glycerol sebacate) (PGS) can be changed
by varying molar ratios during prepolymer synthesis and
by varying curing time. We go on to show that PGS can be
used to create 3D designed scaffolds via solid freeform fab-
rication methods with modulus values that fall within the
ranges of native articular cartilage equilibrium modulus.
Furthermore, using base material modulus inputs, homoge-
nization finite element analysis can effectively predict the
tangent modulus of PGS scaffold designs, which provides a
significant advantage for designing new cartilage regenera-
tion scaffolds. Lastly, we demonstrate that this relatively
new biomedical material supports cartilaginous matrix pro-
duction by chondrocytes in vitro.  2010 Wiley Periodicals,
Inc. J Biomed Mater Res 94A: 9–18, 2010
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INTRODUCTION
Polymer scaffolds will play a key role in treating
cartilage defects, deterioration, and damage caused
by aging, disease, and trauma. There are a number
of synthetic materials and a wide range of fabrica-
tion methods being applied to make such scaffolds,
with the general acceptance that these constructs
should be biocompatible, biodegradable, and
mechanically stable. Here, we focus on the require-
ment that a scaffold should have mechanical proper-
ties, particularly tangent modulus values, in the
range of native cartilage equilibrium modulus val-
ues. There are two components that determine the
final effective scaffold modulus: (1) the base material
modulus and (2) the scaffold pore architecture. As
pore geometry may be restricted by tissue in-growth
requirements, it would be advantageous to be able
to alter effective scaffold modulus simply by altering
the base material modulus. We show how the proc-
essing conditions of poly(glycerol sebacate) (PGS)
can be varied to tailor the mechanical properties of
three-dimensionally designed, solid-freeform fabri-
cated (SFF) scaffolds for cartilage tissue engineering.
Poly(glycerol sebacate) has been recently devel-
oped for tissue engineering.1–13 Synthesis and
characterization of the polymer, created through a
polycondensation reaction of glycerol and sebacic
acid, was first reported for use in biotechnology and
bioengineering in 20021 to provide good mechanical
properties and rubber-like elasticity, established deg-
radation and crosslinking mechanisms optimal for
soft tissue engineering applications. Along with
being tougher, less expensive and more flexible than
existing biodegradable elastomers, glycerol is a hu-
mectant used in foods and beverages, and polymers
containing sebacic acid (e.g., Polifeprosan) have been
approved by the US Food and Drug Administration
for drug delivery applications. To date, PGS has
been studied for applications in nerve guidance,2
soft tissue regeneration,3,4 vascular and myocardial
tissue regeneration,5–9 blood vessel reconstruc-
tion,10,11 drug delivery,12 and replacement of photo-
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receptor cells.13 PGS is a biodegradable polymer
with biocompatibility and mechanical properties that
make it well suited for applications such as those
mentioned and, as we show here, for use in cartilage
tissue engineering.
PGS is processed by creating a prepolymer, and
then curing the prepolymer at high temperatures to
obtain a thermoset elastomeric polymer. Most stud-
ies have fabricated the polymer through conven-
tional methods, creating films or porogen-leached
sponges. The most advanced structures reported are
tubular sheets and films developed as scaffolds for
blood vessels, renal tubules or various ducts.10,11 In
this work, we demonstrate the ability to process PGS
using SFF techniques to create scaffolds with
designed pore shapes, pore sizes, porosities, and
architectures. In the past, this fabrication has been
widely used in our lab14–23 to make designed scaf-
folds from poly(L-lactic acid), poly(lactic-co-glycolic
acid), poly(e-caprolactone), hydroxyapatite, poly(pro-
pylene-fumarate), and poly(propylene-fumarate)/tri-
calcium phosphate blends for applications in bone
regeneration, spinal cord reconstruction, and carti-
lage tissue engineering. Because most of these mate-
rials, when fabricated into three-dimensional (3D)
designed scaffolds, exhibit mechanical properties
that are outside the ranges of cartilage, we have
more recently applied this technology to more elas-
tomeric materials, such as poly(glycerol sebacate)
(PGS) and poly(1,8-octanedial-co-citrate) (POC) for
cartilage tissue engineering applications.24 We
believe that the mechanical properties of these mate-
rials make them ideal for use in fabricating scaffolds
for load bearing articular sites. Fabrication of PGS by
this means is not yet reported.
One of the main advantages of using PGS for
tissue engineering is that its mechanical properties
can be tailored to match specific tissue properties
through altering processing parameters during
the prepolymer and/or curing steps. In 2008,
Chen et al.7 demonstrated the ability to alter the
mechanical properties of PGS for myocardial tissue
applications through changing curing temperature,
recording Young’s modulus values of 0.056 MPa
(1108C), 0.22 MPa (1208C), and 1.2 MPa (1308C). In
this work, we evaluate how changing the molar
ratios of glycerol:sebacic acid during prepolymer
synthesis and how changing the curing time
causes variations in nonlinear elastic mechanical
properties.
The purpose of this work is to assess PGS as a
scaffolding material for cartilage tissue engineering
by determining how synthesis conditions affect both
bulk PGS properties and PGS scaffolds with
designed architecture. As the use of PGS for carti-
lage regeneration has not yet been reported, we fur-
ther demonstrate that PGS scaffolds support robust
cartilage formation when seeded with porcine chon-
drocytes in vitro.
MATERIALS AND METHODS
Fabrication of PGS solid cylinders and
3D-designed scaffolds
Prepolymer synthesis
PGS prepolymer (pPGS) was synthesized following
methods described by Gao et al.4 Three batches of pPGS
were synthesized with various molar ratios of sebacic
acid:glycerol (3:4, 1:1, and 4:3). Sebacic acid and glycerol
were reacted under N2 at 1208C. After 24 h, the N2 was
removed and a vacuum of 50 mTorr was pulled for an
additional 48 h, with a condenser attached.
Polymer curing
Prepolymer was cured through a modified protocol4
that enabled fabrication of designed architecture scaffolds
from wax molds. To create solid cylinders for mechanical
testing, the prepolymer was poured into a Teflon mold
and cured at 1508C for various time points (24 h w/out
vacuum plus 24, 48, or 72 h with a 100 mTorr vacuum). A
3D scaffold (3 mm height, 6.35 mm diameter, 1 mm spher-
ical pores, and 54% porosity) was designed using custom
Interactive Data LanguageTM programs (IDL; Research Sys-
tems, Boulder, CO).15,16 To fabricate designed scaffolds,
wax molds of the final scaffold design were made on a
Solidscape printer (Solidscape, Merrimack, NH). Wax
molds were pressed into hydroxyapatite (HA) following a
protocol previously established in the lab,24 resulting in an
inverse HA mold. The inverse HA mold was pressed into
pPGS that had been poured into a Teflon mold.25 The Tef-
lon/pPGS/HA mold unit was placed within a vacuum
oven to cure at 1508C. For the first 24 h, no vacuum was
pulled, to allow the prepolymer to begin to cure, prevent-
ing air bubbles from forming in the polymer when a vac-
uum is pulled. After 24 h, a strong vacuum (100 mTorr)
was pulled, and the temperature was maintained at 1508C
for 24, 48, or 72 h longer. The HAþPGS construct was
removed from the cup, and the HA was dissolved out
using a rapid decalcifying agent (RDO, Apex Engineering,
Aurora, IL) to achieve the final PGS scaffold. The sche-
matic of this process is shown in Figure 1. PGS scaffolds
and cylinders were autoclaved and rinsed overnight in
DMEM before mechanical testing or chondrocyte seeding.
Cylinder and scaffold diameters were measured before
and after rinsing in DMEM. Note, curing times reported in
the results section refer to the hours cured after a vacuum
was pulled (24, 48, and 72 h).
Fabrication of 3D-designed PCL control scaffolds
For in vitro testing experiments, control 3D polycapro-
lactone (PCL) scaffolds were made using the design previ-
ously described for PGS scaffolds (3 mm height, 6.35 mm
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diameter, 1 mm spherical pores, and 54% porosity). PCL
scaffolds were made by pressing these wax molds directly
into melted 37 kDa polycaprolactone (CAPA 6400, Solvay
Caprolactones, Warrington, Cheshire, UK). Briefly, PCL
pellets were placed into a Teflon mold and melted (1158C,
1 Torr, 120 min). After melting and air bubble removal,
the Teflon mold was pulled from the oven and allowed to
cool for 270 s at room temperature, reaching 808C (just
below the melting temperature of the wax molds). At this
time, inverse wax molds were pressed into the melted
PCL, and the entire construct was cooled overnight. Wax
was dissolved from the PCL using 100% EtOH.
Microcomputed tomography image analysis
To assess defects and create images for finite element
analysis (FEA), solid cylinders and scaffolds were scanned
using a MS-130 high resolution (CT scanner (GE Medical
Systems, Toronto, CAN) at a 16-lm voxel resolution. Scans
were performed in air at 75 kV and 75 mA. GEMS Micro-
view software (GE Medical Systems, Toronto, CAN) was
used to view reconstructed images.
Mechanical testing
Solid PGS cylinders and PGS 3D-designed scaffolds
were tested in compression using an MTS Alliance RT30
electromechanical test frame (MTS Systems Corp., MN).
Stress-relaxation in confined compression
Stress-relaxation tests were performed in confined com-
pression following a protocol established by Guilak et al.26
and used extensively in the field by others.27,28 Briefly,
presoaked samples were loaded into a confining cylindri-
cal chamber filled with a phosphate-buffered saline solu-
tion controlled at 378C. A porous indenter was lowered
until a reading of 0.22N was output on the computer,
signifying that the indenter was in contact with the
cylinder or scaffold. This load was held for 600 s and
assumed to be the 0% strain position. Under displacement
control, stress-relaxation testing was performed with
a single ramp of 20% strain applied at 0.25 lm/s or
5 lm/min. The crosshead was then held at constant
displacement for 30 min to record relaxation.
Unconfined compression
Unconfined compression tests were performed on solid
cylinders (n 5 5–10 for each group, with variation in sam-
ple size due to exclusion of cylinders with defects) under
displacement control. Samples were compressed to failure
in the z-direction between two fixed steel platens at a rate
of 2 mm/min after a preload of 0.05 lb was applied. A sin-
gle set of 3D-designed scaffolds were fabricated (n 5 7)
(1:1 molar ratio, 48 h cure time) and tested in unconfined
compression to validate FEA predictions.
Finite element analysis
Complete anisotropic effective stiffness constants were
calculated using the voxel-based homogenization software
VOXELCON (Quint Corp, Tokyo, Japan), as described pre-
viously.23 STL design files were converted to .vox files,
and PGS modulus values from mechanical testing of solid
cylinders (3 molar ratios 3 3 curing times) were input into




Cartilage was harvested from fresh metacarpophalan-
geal joints of domestic pigs obtained from a local abattoir
Figure 1. Fabrication of 3D designed PGS scaffolds involves first creating wax molds, which are cast into hydroxyapatite
to create an inverse mold, which is then cast into PGS prepolymer and cured, resulting in a PGS scaffold.
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(Northwest Market, Northwest, MI). Cartilage pieces were
digested in a digest solution [DMEM high glucose, serum
free, 1 mg/mL collagenase II (Sigma No. C1764), 2% Pen/
strep, 2% kanamycin (Roche, 12728700), and 0.2% Fungi-
zone (Invitrogen, 15290-018)] on a stir plate for 6 h at 378C,
5% CO2. The solution was then filtered through sterile ny-
lon. Cells were spun at 2000 rpm for 8 min, and plated
overnight on tissue culture polystyrene in DMEM þ
10%FBS þ 1% P/S þ 50 lg/mL 2-phospho-L-ascorbic acid
(BioChemika, 49752). The following day, cells were trypsi-
nized and immediately suspended in collagen gel for scaf-
fold seeding.
Cell seeding and in vitro culture
PGS scaffolds (1:1 molar ratio, 48 h cure time) were
sterilized in an autoclave and presoaked in DMEM for
24 h before cell seeding. Chondrocytes were suspended in
a composite 5% Hyaluronic Acid (HyA) (stock concentra-
tion: 2.7 mg/mL in 0.8M NaCl, MW: 3 3 106 Da: Hyalogic
LLC, Edwardsville, KS) info)/collagen I gel (stock concen-
tration: 5.9 mg/mL, BD Biosciences, No. 354236) at
30 3 106 cells/mL. 4% v/v 0.5M sodium hydroxide with
220 mg/mL sodium bicarbonate was used to increase the
pH of the collagen/HyA/cell suspension just before seed-
ing into the scaffolds to create gelling at 378C. Cells were
evenly seeded into scaffolds using a custom designed Tef-
lon mold. After gelling (30 min), scaffolds were removed
from the mold. Scaffold þ Cells þ Gel constructs were cul-
tured in an incubator (378C, 5% CO2) in 24-well plates on
an orbital shaker for 2 weeks. Media (DMEM, 10%FBS, 1%
P/S, 0.1 mM nonessential amino acids, 50 lg/mL 2-phos-
pho-L-ascorbic acid, 0.4 mM proline, 5 lg/mL insulin) was
changed every other day. PCL control scaffolds were
seeded and cultured in the same manner.
Histological staining
After 2 weeks, PGS scaffolds (n 5 2) were removed,
fixed in 10% buffered formalin phosphate (Fisher, SF100-
20) overnight, dehydrated in EtOH washes, and paraffin
embedded. Histological sectioning was performed 1500
lm from the scaffold surface (at approximately the mid
point of the scaffold) and sections were stained with
Alcian Blue to illustrate GAG production.
Sulfate-glycosaminoglycan (sGAG) quantification
At 2 weeks, PGS scaffolds (n 5 3) and control PCL scaf-
folds (n 5 3) were removed from culture, finely chopped,
and placed immediately into 1 mL of papain solution (pa-
pain, 13 PBS, cysteine HCL, EDTA, pH 5 6.0; mixed for 3
h at 378C then filtered). Scaffolds were digested in papain
for 24 h and then immediately frozen at 2208C. A DMMB
assay was run on digested scaffolds. Briefly, 20 lL of sam-
ple was mixed with 200 lL of dimethylmethylene blue rea-
gent and absorbance was immediately read on a plate
reader (MultiSkan Spectrum, Thermo, Waltham, MA) at
525 nm.29 Readings were compared with a standard curve
established from chondroitin 6-sulfate from shark (Sigma,
C4384).
DNA quantification
Papain digested PGS scaffolds (n 5 3) and control PCL
scaffolds (n 5 3) were also used to determine DNA con-
tent through a Hoechst 33258 Assay (Sigma, No. 861405).
Briefly, 100 lL digested sample was added to 100 lL
Hoechst and read with excitation: 355 nm, emission:
460 nm (Fluoroskan Ascent FL, Thermo, Waltham, MA) in
a 96-well plate. Readings were compared with standards
made from calf thymus DNA (Sigma, No. D0805).
Quantitative-PCR
qtPCR was used to determine the expression of cartilage
specific genes (collagen II and aggrecan), a chondrocyte
dedifferentiation marker (collagen I), and a house-keeping
gene (GAPDH). Scaffolds were removed from culture,
rinsed twice with PBS, cut into small pieces (1 mm3),
and placed immediately into RNAlater (Qiagen, D-40724).
Scaffolds were incubated in RNAlater at 48C for 24 h then
transferred to 2208C for storage. For RNA extraction, scaf-
fold þ tissue were homogenized in Buffer RLT for 60 s.
Lysate was then centrifuged, and supernatant was
removed. RNA was extracted using an RNeasy Mini Kit
(Qiagen No. 74104), and samples were stored at 2808C.
After measurement of RNA concentration for each sample,
first-stand cDNA was synthesized using random primers
(Superscript Kit No. 18064). Samples were prepared for
qtPCR using a Taqman universal PCR master mix
(Applied Biosystems, 4304437) and custom designed por-
cine primers. qtPCR was then performed using an ABI
PRISM 7700 (Applied Biosystems, Foster City, CA). As a
control, before seeding, 5 3 106 chondrocytes were incu-
bated in RNAlater and used for qtPCR.
Statistical analysis
Multiple linear regression was performed using SPSS
software (SPSS for Windows, Rel 14.0. 2005 Chicago: SPSS).
RESULTS
Fabrication of cylinders and scaffolds
Caliper measurements of PGS cylinder and scaf-
fold diameters showed no significant swelling of
constructs after soaking in DMEM for 24 h (average
solid cylinder diameter before DMEM soak 5 6.45
mm 6 0.03 mm, after soaking 5 6.46 mm 6 0.03
mm; average scaffold diameter before DMEM soak 5
6.43 mm 6 0.03 mm, after soaking 5 6.44 mm 6
0.02 mm). Micro-CT analysis of solid cylinders
confirmed the absence of air bubble defects in these
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mechanical testing specimens. Successful fabrication
of designed scaffolds can be seen in Figure 2, where
l-CT analysis of scaffolds, again, confirms the absence
of defects [Fig. 2(a,b)]. Volume fraction quantification
done on l-CT images reveals that the porosity of fabri-
cated scaffolds (48.1% 6 4.24%) is slightly less than
that of the design file (54%), whereas scaffold pore
diameters (1.04 mm 6 0.04 mm) are equal to designed
pore sizes (1.0 mm). Decreased porosity of actual
scaffolds is most likely due to small amounts of PGS
penetrating into pores.
Mechanical property variations
Stress-relaxation testing done on solid cylinders (n 5
2 for each molar ratio/cure time) revealed that PGS
does not exhibit a viscoelastic response. Stress-relaxa-
tion profiles were not dependent on strain rate (0.25
lm/s vs. 5 lm/s), nor did they relax under constant
displacement after loading (Fig. 3), indicating that PGS
exhibited predominantly elastic properties and there-
fore, PGS bulk and scaffolds were tested in unconfined
compression and fit to a 1D nonlinear elastic model
commonly used for biological soft tissues:
T ¼ A eBe  1
 
where T is the 1st Piola-Kirchoff stress, e is the large
strain, and A and B are model parameters fit to
experimental data. The fit was performed using a spe-
cially written MATLAB program calling the optimiza-
tion function fminunc. The tangent modulus at 10%
strain was calculated as follows:
Figure 2. Successfully fabricated 3D-designed PGS scaffolds illustrated through micro-CT images, side view (a) and top
view (b) and digital images, side view (c) and top view (d) show no defects.
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Representative curve fits for solid cylinders and
3D scaffolds can be seen in Figure 4.
As seen in Figure 5, the tangent elastic modulus of
PGS is significantly altered through variations in
prepolymer molar ratios and curing times. Multiple
regression provided a powerful (predictive power,
adjusted R2 5 0.70) linear equation for tangent
Figure 4. A 1D nonlinear elastic model provides a good fit for solid PGS cylinders (a) and 3D-designed scaffolds (b).
Figure 3. Evidence that PGS does not exhibit viscoelastic characteristics is illustrated when (a) the stress–strain response
for solid PGS cylinders is not dependent on strain rate, (b) stress-relaxation of bulk PGS is not demonstrated during fast
or slow ramping speeds, (c) there is no stress-relaxation response of a 3D PGS scaffold, when compared with (d) the visco-
elastic response of cartilage shown by Soltz and Ateshian.27
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modulus (at 10% strain) dependent on these two
variables: y 5 3.607–1.410 * (molar ratio of glycerol:
sebacic acid) þ 0.60 * (curing time in hours).
Homogenization finite element analysis
Homogenization FEA was used to calculate the
tangent elastic modulus values of scaffold design
files and l-CT images of actual scaffolds using val-
ues of solid cylinder tangent modulus at 10%
strain. Table I displays experimental modulus val-
ues of solid cylinders, FEA predictions of modulus
values for a 3D scaffold from design files, and
modulus values from experimentally tested scaf-
folds. The voxel model is able to accurately predict
the tangent modulus of scaffolds from the design
file (prediction 5 0.60 MPa, actual 5 0.57 6 0.24).
In vitro study
Chondrocytes suspended in collagen 1/5% hyal-
uronic acid composite hydrogel within 3D designed
scaffolds maintained a rounded morphology and
produced a cartilaginous matrix as seen in digital
images and through alcian blue staining in Figure 6.
Sulfated-GAG concentrations were within the same
ranges as chondrocytes cultured under identical con-
ditions on poly(e-caprolactone) (PCL) of the same
architectural design (29.64 6 11.87 vs. 33.00 6
6.24 lg GAG/lg DNA, respectively). Collagen 2: col-
lagen 1 ratios were higher for chondrocytes cultured
on PGS than those cultured under identical condi-
tions on PCL (20.91 6 3.25 vs. 8.69 6 0.17), but were
lower than mRNA expression by unseeded chondro-
cytes (267). Aggrecan expression by cells on PGS
was similar to cells seeded on PCL (1.74 6 0.68 vs.
1.67 6 0.07), and both expression levels were higher
than expressed by preseeded chondrocytes (0.37).
Note: ‘‘preseeded’’ refers to an aliquot of cells taken
immediately before seeding the batch of cells onto a
scaffold.
DISCUSSION AND CONCLUSIONS
We have presented a novel PGS scaffold fabrica-
tion method. Actual scaffold pore sizes and poros-
ities showed no major deviations from design files,
and there is no significant swelling of solid cylinders
or scaffolds when they are soaked in DMEM.
It is highly desirable to be able to match effective
scaffold mechanical properties to native tissue prop-
erties for scaffolds designed for optimal tissue regen-
eration. Intuitively, one way in which the mechanical
Figure 5. Tangent Modulus (at 10% strain) values for
PGS cylinders with various processing parameters. Linear
regression can be used to predict the modulus (70%
power) from these two variables: Modulus (MPa) 5 3.607–
1.410 * (ratio of glycerol:sebacic acid) þ 0.60 * (vacuum
curing time in hours).
TABLE I
Modulus Values of Solid PGS Cylinders Made from Varying Glycerol:Sebacic Acid Molar Ratios and Varying Curing
Times Were Used in FEA to Predict the Modulus Value of Scaffolds that Could Be Made Using the Same Conditions
Tangent Modulus (MPa) (at 10% Strain)
Cure
Time






24 2.34 6 0.837 1.73 6 0.9210 0.13 6 0.125 0.62 0.46 0.03
48 3.05 6 0.719 2.29 6 0.6110 0.40 6 0.178 0.81 0.60 0.11 0.57 6 0.24
72 4.28 6 1.158 2.82 6 0.498 0.71 6 0.387 1.13 0.75 0.19
3:4 1:1 4:3 3:4 1:1 4:3 3:4 1:1 4:3
Molar Ratio (glycerol:sebacic acid)
Scaffolds were tested experimentally to verify predictions.
*Sample size (n) is displayed in superscript for each group.
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properties of a scaffold can be altered is through
changing the structural features, such as pore size,
porosity, interconnectivity, and pore shape.15,30
However, changing these features also has an effect
on cartilage tissue regeneration.31–36 Working with a
material whose intrinsic elastic properties can be
altered enables fabrication of scaffolds with a wide
range of architectures (designed for optimal tissue
regeneration) from one material, all of which will
support in vivo loads. PGS is beneficial in this
respect, as its mechanical properties can be varied
simply through changing the molar ratios of glycerol
to sebacic acid during prepolymer synthesis or vary-
ing the duration of curing.
After establishing a collection of bulk mechanical
properties for nine processing combinations (3 molar
ratios 3 3 curing times), we used FEA to predict the
elastic moduli of a 3D designed scaffold fabricated
from these various batches of PGS. A single batch of
scaffolds, fabricated from an intermediate of the nine
processing combinations, verified that modulus val-
ues reported through FEA are reasonable estimates.
This demonstrates the ability of image-based homog-
enization FEA to compute the effective tangent mod-
ulus of PGS scaffolds without the need for destruc-
tive testing.
Although PGS does not exhibit viscoelastic proper-
ties, the ability to match the elastic modulus of scaf-
folds to the equilibrium elastic properties of native
cartilage is a step in the right direction, as this com-
ponent is responsible for providing shape retention
and strength. In comparison, a current clinical treat-
ment, autologous chondrocyte implantation, has
shown some success without any substantial mechan-
ical support.37 However, patients must be extremely
careful not to overload the delicate periosteal flap
which envelopes the repair site. This draws a thin
line between the amount of postoperative mechanical
loading shown to enhance tissue regeneration, and
the amount that will damage the graft.38 Incorporat-
ing a scaffold that matches the equilibrium elastic
properties of native articular cartilage will allow for
some degree of postoperative loading, a more robust
environment to retain cell implantation, and tempo-
rary mechanical support that closely mimics the sup-
port provided by surrounding healthy tissue. Fur-
thermore, this data can be applied to other soft tissue
engineering applications that PGS is being studied
for, such as myocardial tissue,7 where nonlinear elas-
tic properties are highly desirable.
Figure 6. Digital images and histological sections (stained with alcian blue) show in vitro growth of cartilaginous tissue
into PGS scaffolds. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
Figure 7. The FEA-predicted modulus values for this par-
ticular scaffold design fabricated from the collection of
PGS bulk properties studied, range from 0.03 to 1.13 MPa,
completely encompassing the native articular cartilage val-
ues that one might wish to match.
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The equilibrium elastic properties of experimental




ð1þ vÞð1 2vÞ þ
2E
3ð1 2vÞ
where HA is the aggregate modulus, E is the equilib-
rium elastic component of this modulus, and v is the
Poisson’s ratio. Poisson’s ratio was assumed to be
0.3, as experimentally measured by Cohen et al.39
With literature showing HA values of healthy articu-
lar cartilage ranging from 0.089 MPa to 2.22
MPa,27,28,40–48 the calculated equilibrium elastic com-
ponent (E) ranges from 0.04 to 0.99 MPa. As dis-
played in Figure 7, elastic modulus values predicted
for this particular scaffold design from the collection
of PGS bulk properties range from 0.03 to 1.13 MPa,
completely encompassing the native tissue values
that one might wish to match.
Furthermore, an in vitro experiment shows that
PGS can indeed be used for cartilage tissue engineer-
ing applications where chondrocytes are seeded
within a scaffold to produce a cartilaginous matrix.
Aggrecan is expressed in higher levels on PGS scaf-
folds than in preseeded cells, showing favorable
trends toward chondrogenesis. Collagen 2: collagen
1 ratio, commonly referred to as a ‘‘differentiation
index’’ for chondrocytes,49 where a larger value rep-
resents more chondrogenic gene expression and a
lower value represents more fibroblastic gene
expression, is higher on PGS than on identical stud-
ies done using PCL. Differences between expression
levels on PGS versus PCL may be related to the
hydrophilicity of PGS which may enhance cell adhe-
sion, retain more sGAG, and more closely mimic the
native hydrophilic nature of cartilage ECM; how-
ever, further studies need to be done to verify this
hypothesis.
PGS is a good candidate for cartilage tissue engi-
neering applications. As shown for the first time, it
can be fabricated into 3D-designed scaffolds using
SFF techniques and is biocompatible with chondro-
cytes in vitro. Its bulk mechanical properties can be
altered during synthesis and curing to match stiff-
ness values of 3D-designed scaffolds to those of
native cartilage. Furthermore, scaffold modulus val-
ues can be predicted using FEA, eliminating the
need for destructive testing on custom scaffolds.
The authors thank Claire Jeong for fabricating many of
the wax and HA molds used in this study.
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